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        Introduction 
  In eukaryotic cells, communication between the cytoplasm and 
nucleus is of central biological importance for the integration of 
cytoplasmic signaling, cytoskeletal organization, and the dy-
namic regulation of nuclear gene expression (  Schwoebel and 
Moore, 2000  ;   Xu and Massague, 2004  ;   Davis et al., 2007  ). 
For proteins too large to diffuse through the nuclear pore complex, 
the regulation of nuclear localization by karyopherins and the 
Ran gradient are extensively understood (  Mattaj and Englmeier, 
1998  ;   Pemberton and Paschal, 2005  ). However, the functional 
signifi  cance and molecular mechanisms by which proteins that 
lack classical nuclear localization sequences are traffi  cked re-
main poorly studied. The scale of this gap in knowledge is illus-
trated by the fi  nding that 43% of nuclear-located proteins of 
  Saccharomyces cerevisiae   do not have classical nuclear import 
motifs (  Lange et al., 2007  ). Furthermore, this fi  gure does not 
include cytoplasmic-located proteins that enter the nucleus in 
response to specifi  c cues. In this paper, we have identifi  ed a 
novel process involving the cytoplasmic protein muskelin that 
connects the regulation of cell morphology with nucleocyto-
plasmic communication. 
  Muskelin is an intracellular multidomain protein that was 
identifi  ed in an expression cloning screen for proteins function-
ally involved in cell spreading responses to the extracellular 
T
he evolutionarily conserved kelch-repeat protein 
muskelin was identiﬁ  ed as an intracellular mediator 
of cell spreading. We discovered that its morpho-
logical activity is controlled by association with RanBP9/
RanBPM, a protein involved in transmembrane signaling 
and a conserved intracellular protein complex. By sub-
cellular fractionation, endogenous muskelin is present in both 
the nucleus and the cytosol. Muskelin subcellular localiza-
tion is coregulated by its C terminus, which provides a 
cytoplasmic restraint and also controls the interaction 
of muskelin with RanBP9, and its atypical lissencephaly-1 
homology motif, which has a nuclear localization activity 
which is regulated by the status of the C terminus. Tran-
sient or stable short interfering RNA  –  based knockdown 
of muskelin resulted in protrusive cell morphologies with 
enlarged cell perimeters. Morphology was speciﬁ  cally re-
stored by complementary DNAs encoding forms of mus-
kelin with full activity of the C terminus for cytoplasmic 
localization and RanBP9 binding. Knockdown of RanBP9 
resulted in equivalent morphological alterations. These 
novel ﬁ  ndings identify a role for muskelin  –  RanBP9 com-
plex in pathways that integrate cell morphology regula-
tion and nucleocytoplasmic communication.
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fractionation of C2C12 skeletal myoblasts that have high levels 
of muskelin (  Adams et al., 1998  ). Full-length muskelin was 
present in cytosol and the high-salt nuclear extract that is en-
riched for nonstructural nuclear proteins such as Ran (  Fig. 1 A  ). 
The generality of full-length nuclear muskelin was established 
by its detection in human aortic smooth muscle cells and human 
SW1222 carcinoma cells (unpublished data). Recently, nuclear 
muskelin was reported in hippocampal neurons by immuno-
fl  uorescence (  Tagnaouti et al., 2007  ). 
glycoprotein thrombospondin-1 (TSP-1;   Adams et al., 1998  ). 
Muskelin is a member of the kelch-repeat superfamily, which 
includes numerous proteins with roles in actin binding or the 
regulation of ubiquitin-mediated protein degradation (  Bork and 
Doolittle, 1994  ;   Adams et al., 2000  ;   Kobayashi and Yamamoto, 
2005  ). The muskelin transcript is expressed throughout life 
in multiple tissues, including skeletal and smooth muscle, the 
central nervous system, and lung, and is up-regulated in several 
pathological conditions, including periodontitic neutrophils, 
ischemic vascular smooth muscle cells, and hyperosmotic inter-
vertebral discs (  Adams et al., 1998  ;   Adams and Zhang, 1999  ; 
  Kubota et al., 2001  ;   Dhodda et al., 2004  ;   Boyd et al., 2005  ;   Ledee 
et al., 2005  ;   Prag et al., 2007  ;   Tagnaouti et al., 2007  ). The domain 
architecture of muskelin includes an amino-terminal discoidin-
like domain (DD), a central     -helical region with lissencephaly-1 
(LIS1) homology (LisH) and C-terminal to LisH (CTLH) motifs, 
six kelch repeats that form a      propeller structure, and a unique 
carboxyl-terminal region (  Adams et al., 1998  ;   Adams, 2002  ; 
  Prag et al., 2004  ;   Li et al., 2004  ). 
  Muskelin is unique within the kelch-repeat family: in addi-
tion to its unique domain architecture it has a unique phylo-
genetic distribution, being conserved in the animal, fungal, and 
protozoal kingdoms (  Prag and Adams, 2003  ;   Prag et al., 2004  ). 
In contrast, TSPs are restricted to the animal kingdom. Thus, it 
is likely that muskelin has additional TSP-independent cellular 
roles. Although cytoplasmically located and linked functionally 
to cytoskeletal organization in several cell types, muskelin does 
not specifi  cally colocalize with F-actin or microtubules and is 
not a direct binding partner for monomeric or polymerized actin 
or tubulin (  Adams et al., 1998  ;   Prag et al., 2004  ). These fi  ndings 
motivated us to establish how muskelin participates in both 
TSP-dependent and -independent pathways. 
 Muskelin binding proteins reported from yeast two-hybrid 
screens include EP3     prostaglandin receptor, RanBP9/RanBPM, 
and the p39 activator of cyclin-dependent kinase 5 (  Hasegawa 
et al., 2000  ;   Umeda et al., 2003  ;   Ledee et al., 2005  ). However, 
the tissue-restricted expression patterns of EP3     receptor and 
p39 are not congruent with a general signifi  cance for muskelin 
function in the many tissues where it is expressed. Additional 
complexity has been suggested by reports that muskelin and 
RanBP9 are components of a protein complex of unknown 
function that includes several nucleocytoplasmic proteins (  Umeda 
et al., 2003  ;   Kobayashi et al., 2007  ). In this paper, we establish 
that RanBP9 binding is needed for activity of muskelin in cell 
spreading and is integrated with mechanisms that regulate the 
distribution of muskelin between cytoplasm and nucleus. These 
data advance concepts of mechanisms of regulatory communi-
cation between the cytoplasm and the nucleus. 
  Results 
  Endogenous muskelin includes a 
nuclear pool 
  Muskelin is present in cytoplasm, yet a possible nuclear com-
ponent was suggested by studies of GFP-tagged muskelin, and 
RanBP9 is present in both cytoplasm and the nucleus (  Prag et al., 
2004  ;   Denti et al., 2004  ). We undertook rigorous subcellular 
  Figure 1.        Muskelin is a nucleocytoplasmic protein.   (A) Western blots 
of subcellular fractions of C2C12 cells, equalized for protein load, were 
probed with antibodies to muskelin and also with GAPDH, Ran, and lamin B1 
as quality control markers for the fractionation. Cy, cytosol; M, membranes; 
NE, nuclear extract; NP, nuclear pellet. Results are representative of three 
experiments. (B and C) The panel of muskelin domain proteins. (B) Schematic 
of muskelin domain deletions. (C) Representative expression levels of GFP-
tagged muskelin domain deletion proteins in COS-7 cells. An overexposure 
to reveal the poorly expressed GFP-MKDDLH is shown on the right. All molec-
ular mass markers are shown in kilodaltons.     729 MUSKELIN  –  R  AN  BP9 COMPLEX AND CELL MORPHOLOGY   • Valiyaveettil et al. 
  GFP-MK was cytoplasmic in comparison to GFP alone 
and had the same distribution as endogenous muskelin (  Fig. 2 A  , 
xy and xz images of GFP-MK;   Adams et al., 1998  ). We reported 
previously that GFP-MKDD (45.5 kD) is below the size thresh-
old for diffusion through nuclear pores (  Prag et al., 2004  ). 
The C-terminal domain alone, GFP-MKC35 (31.2 kD), is also 
below this threshold and also localized in the nucleus and cyto-
plasm indistinguishably from GFP (  Fig. 2 A  ). Thus, neither the 
DD nor the C35 region contains active nuclear localization or 
export motifs. However, deletion of the C-terminal 35 aa (GFP-
MK    C35, predicted molecular mass 108.3 kD) resulted in a 
predominantly nuclear localization in 70% of the transfected 
cells. GFP-MK    C35 was present in the nucleoplasm with ex-
clusion from nucleoli, as established by costaining cells for the 
nucleolar component fi  brillarin and examining confocal images 
  Muskelin localization in cells is balanced 
by distinct domains 
  Toward defining the mechanisms underlying the multi-
ple subcellular localizations of muskelin, we analyzed how 
muskelin domains contribute to its distribution. A panel of 
GFP-tagged mouse muskelin domain deletion mutants were 
developed according to the domain boundaries assigned from 
bioinformatic analyses (  Fig. 1 B  ;   Prag et al., 2004  ). With the 
exception of GFP-MKDDLH, the proteins were expressed at 
similar levels (  Fig. 1 C  ). The subcellular localization of these 
proteins was examined in COS-7 epithelial cells (muskelin 
negative), C2C12 skeletal myoblastic cells, and mouse em-
bryo fi  broblasts (both muskelin positive), with identical re-
sults for all cells. Only results from COS-7 cells are depicted 
in fi  gures. 
  Figure 2.       Muskelin domain deletion proteins 
have distinct subcellular localizations.   (A) Lo-
calization of GFP-MK and the panel of mus-
kelin domain deletions, as shown in   Fig. 1 B  , 
visualized in ﬁ  xed COS-7 cells by laser scan-
ning confocal microscopy. Merged images 
show GFP proteins (green) and DAPI-stained 
nuclei (blue). For HA-DDL, anti-HA staining is 
green. Images are in the xy plane unless other-
wise indicated. Exclusion of nuclear-located 
MK    C35 from nucleoli is demonstrated in 
the inset and xz panels as merged images of 
GFP-MK    C35 (green) and anti-ﬁ  brillarin (red) 
staining. Bars, 10   μ  m. (B) Quantiﬁ  cation  of 
the subcellular localizations of GFP-tagged 
muskelin domain deletion proteins by a ﬁ  ve-
point scoring scheme. The major localization 
of each protein is also shown schematically. 
All localizations were scored blind by two in-
dependent observers. Each column represents 
the mean from three to ﬁ  ve  independent  ex-
periments. Error bars indicate SEM. At least 
1,000 cells were scored for each construct.     JCB • VOLUME 182 • NUMBER 4 • 2008  730
  Fig. 2  ); third, in the absence of C35 and the presence of the 
LisH motif, the major localization is in the nucleus; and fourth, 
any combination of the HKC domains partitions between nu-
cleus and cytoplasm. 
  Muskelin does not undergo chromosome 
maintenance region 1 (Crm1)  –  mediated 
nuclear export 
  The propensity of GFP-MK    C35 to localize to the nucleus 
could theoretically result either from deletion of a nuclear ex-
port sequence (NES) located in C35 or the dysregulated activity 
of a NES or NLS elsewhere in the protein. Because GFP-MKC35 
had the same distribution as GFP (  Fig. 2 A  ), our experiments 
did not support the presence of an NES in C35. An active NES 
would cause GFP to accumulate in the cytoplasm (  Itahana et al., 
2006  ). To examine whether a Crm1-dependent NES is present 
elsewhere within muskelin, GFP-MK  –  expressing cells were 
treated with leptomycin B to inhibit Crm1-mediated nuclear ex-
port (  Fukuda et al., 1997  ;   Wolff et al., 1997  ). After treatments 
from 30 min to 18 h, GFP-MK did not accumulate in the nucleus 
(  Fig. 3  , shown for 18-h treatment). Under the same conditions, 
cyclin B, which undergoes leptomycin B  –  sensitive nuclear ex-
port (  Yang et al., 1998  ), became concentrated in the nucleus 
(  Fig. 3 B  ). Thus, Crm1-mediated nuclear export of muskelin was 
not apparent. 
  The LisH motif of muskelin has nuclear 
localization activity 
  From all the data in the previous sections, we hypothesized that 
the LisH motif of muskelin (LisH  MK  ) has a major role in regu-
lating the nuclear localization of muskelin. The LisH motif was 
identifi  ed originally as a short     -helical region at the amino 
terminus of LIS1 that is present in many other proteins (  Emes 
and Ponting, 2001  ). In LIS1, the motif contributes to homo-
dimerization (  Cahana et al., 2001  ;   Kim et al., 2004  ). Although all 
muskelins contain a central region with predicted    -helical  sec-
ondary structure, not all contain motifs identifi  ed by the simple 
modular architecture research tool (SMART) database as LisH 
motifs (  Prag et al., 2004  ). Thus, the relationship with LIS1 
might not be the optimal way to consider the signifi  cance of 
this region of muskelin. We made an unbiased evaluation of the 
LisH  MK   sequence by the Sequence Logo method, a graphical 
method that displays the information content of a set of aligned 
sequences more comprehensively than a standard consensus se-
quence (  Shaner et al., 2003  ). The Sequence Logo of LisH from 
12 muskelins from chordates, insects, and fungi revealed strong 
conservation of multiple residues including arginines at posi-
tions 3 and 9, clustered basic residues at positions 13  –  16, and 
certain fl  anking acidic and neutral residues (  Fig. 4 A  ; top). 
These conserved charged residues distinguish LisH  MK   from the 
general Sequence Logo for a LisH motif from these eukaryotes 
( Fig.  4 A ,  bottom). 
 The  LisH MK   consensus is distinct from a classical NLS 
(  Mattaj and Englmeier, 1998  ). To test whether LisH  MK   confers 
nuclear import on a heterologous protein, we engineered a chi-
mera of LisH  MK   with vinculin, a 1,068-aa 117-kD cytoplasmic 
protein that associates with F-actin and focal adhesions (  Zamir 
in the xy and xz planes (  Fig. 2 A  ). Because this large protein is 
above the molecular mass limit for diffusion through the nuclear 
pore complex, this result suggested the possible existence of 
nuclear localization or traffi  cking motifs within MK   C35. 
 A  fi  ve-point scoring scheme was used to quantify the lo-
calization of the different domain deletion proteins (  Fig. 2 B  ). 
GFP-MKDD and GFP-MKC35 were excluded from this scoring 
because of their diffusion properties. GFP-MKDDLH (57.3 kD) 
was excluded because of its poor expression (  Fig. 2 B  ). In the 
few cells where MKDDLH was detectable, it formed large cyto-
plasmic puncta (  Fig. 2 A  ). Analysis of the other domain proteins 
revealed that GFP-MKDDL, although only 4 kD larger than 
GFP-MKDD, localized strongly to the nucleus with exclusion from 
nucleoli (  Fig. 2   and not depicted). GFP-MKLHKC (93 kD) was 
mainly cytoplasmic, whereas GFP-MKLHK (89.4 kD) had pro-
nounced nuclear localization (compare micrographs in   Fig. 2 A  ). 
Other domain combinations from the C-terminal region of mus-
kelin were the following: GFP-MKHKC (88.3 kD); GFP-MKHK 
(84.9 kD); GFP-MKKC (83.9 kD), and the kelch-repeats alone, 
GFP-MKK (78.8 kD), all distributed uniformly between the nu-
cleus and the cytoplasm (  Fig. 2  ). Additional experiments with 
infl  uenza HA epitope-tagged MKDDL (HA-MKDDL; 24.7 kD) 
confi  rmed that the strong nuclear localization of MK-DDL was 
independent of GFP (  Fig. 2 A  ). 
  These results revealed the following unexpected novel 
attributes of muskelin: First, its cytoplasmic localization de-
pends on a cytoplasmic restraint, apparently provided by the 
C35 region; second, this restraint is only active in proteins that 
also contain the LisH motif (compare the major changes in 
distribution between WT and     C35 or LHKC and LHK, with 
the very similar distributions of HKC and HK or KC and K; 
  Figure 3.       Muskelin does not undergo Crm1-mediated nuclear export.   
(A) Localization of GFP-MK in COS-7 cells treated with solvent (Con) or 
10   μ  g/ml leptomycin B for 18 h. Bar, 10   μ  m. (B) Quantiﬁ  cation of the 
cellular localizations of GFP-MK or cyclin B1 in cells treated with solvent 
or 10   μ  g/ml leptomycin B for 18 h. Only the distribution of cyclin B1 was 
signiﬁ  cantly altered (*, P   <   0.001). Each column represents the mean from 
three independent experiments. Error bars indicate SEM. At least 100 cells 
were scored in each experiment.     731 MUSKELIN  –  R  AN  BP9 COMPLEX AND CELL MORPHOLOGY   • Valiyaveettil et al. 
yet, in comparison to the mainly nuclear location of GFP-
MK   C35,  GFP-MK   C35/LisHAA had a dramatically altered 
uniform distribution between the nucleus and cytoplasm (  Fig. 4, 
F and G   [quantifi  cation]). This result was consistent with de-
creased nuclear entry of GFP-MK    C35/LisHAA, as seen with 
the vinculin-LisHAA chimera. Counterintuitively, the point muta-
tions in the context of full-length muskelin (GFP-MK/LisHAA) 
markedly increased the percentage of cells with equivalent cyto-
plasmic and nuclear muskelin compared with GFP-MK (  Fig. 4, 
F and G   [quantifi  cation]). This unexpected result pointed to the 
existence of additional intramolecular determinants that regu-
late muskelin nuclear localization. 
  The C35 region regulates the 
nucleocytoplasmic distribution of 
muskelin and RanBP9 binding 
  On the basis of our results and that C35 acts as a cytoplasmic 
restraint for full-length muskelin (  Fig. 2  ), we hypothesized that 
LisH  MK   and C35 cocontrol the localization of full-length muske-
lin. To explore this concept, we analyzed the sequence of C35 for 
and Geiger, 2001  ). Chimerization of vinculin with GFP (add-
ing 265 aa, resulting in a predicted molecular mass of 143.9 kD; 
  Fig. 4 B  ) did not alter the normal localization of vinculin in 
cytoplasm, membrane ruffl  es, and adhesion sites (  Fig. 4, C and D   
[quantification]). In contrast, the addition of LisH  MK   (37  aa, 
resulting in a predicted molecular mass of 121.5 kD) did not 
change the expression level of the protein (  Fig. 4 B  ) yet caused 
dramatic relocalization to the nucleus (  Fig. 4, C and D   [quanti-
fi  cation]). To establish the role of the LisH  MK   basic cluster in 
this relocalization, we prepared a double alanine point muta-
tion of positions 13 and 14 (  Fig. 4 A  , Sequence Logo). Vinculin-
LisHAA had a majority cytoplasmic localization (  Fig. 4, 
C and D   [quantifi  cation]). These experiments establish that 
LisH  MK   can independently import a heterologous protein into 
the nucleus and that an intact basic cluster is necessary for 
this activity. 
  To establish the functional role of LisH  MK   within muske-
lin itself, we generated the same alanine point mutations in the 
context of GFP-MK    C35 or GFP-MK. Both proteins were ex-
pressed at the same level as their control counterparts (  Fig. 4 E  ) 
  Figure 4.       The LisH motif of muskelin has 
nuclear localization activity.   (A) Sequence Lo-
gos for the consensus LisH motif of muskelin 
(LisH  MK  ), derived by alignment of LisH motifs 
from 12 muskelin sequences from vertebrates, 
insects, and fungi, and the general consensus 
for a LisH motif, derived by alignment of 120 
LisH motifs from vertebrates, insects, and fungi 
in the SMART database. Amino acids are 
shown in single letter code. The total height 
at each position is a measure of the strength 
of conservation at that position. Letter heights 
display the relative conservation of individual 
amino acids at that position. (B) Vinculin reporter 
constructs prepared without or with C-terminal 
fusion of GFP or LisH  MK   were expressed in 
COS-7 cells. Immunoblots of 5 and 20   μ  g of 
each whole cell extract demonstrate equiva-
lent expression of vinculin, vinculin-LisH  MK  , 
and vinculin-LisHAA and higher expression of 
vinculin-GFP. Arrows indicate the ectopically 
expressed vinculins and asterisks indicate 
the endogenous vinculin. (C) LisH  MK   mediates 
nuclear localization of vinculin. Confocal xy or 
xz images of anti-vinculin  –  stained COS-7 cells 
expressing the indicated constructs. Bars, 10   μ  m. 
(D) Quantiﬁ  cation of subcellular localizations 
of vinculin reporter proteins. Each column 
represents the mean from three independent 
experiments. Error bars indicate SEM. At least 
500 cells were scored for each construct. 
(E) Immunoblot demonstrates equivalent ex-
pression of GFP-MK and GFP-MK    C35, with-
out or with point mutation of LisH  MK  , in COS-7 
cells. Molecular mass markers are shown in 
kilodaltons. (F) Merged confocal images of 
representative localizations of the indicated 
GFP-tagged proteins (green) and DAPI-stained 
nuclei (blue). Bar, 10   μ  m. (G) Quantiﬁ  cation of 
subcellular localizations. Each column repre-
sents the mean from three to ﬁ  ve independent 
experiments. Error bars indicate SEM. At least 
500 cells were scored for each construct.     JCB • VOLUME 182 • NUMBER 4 • 2008  732
had nuclear muskelin compared with 70% of GFP-MK   C35  cells; 
  Fig. 2 B  ). Identical results were obtained in COS-7, C2C12, and 
A549 cells (  Fig. 5, C and D  ; shown for COS-7 only). Proteins 
mutated in both the TPPK motif and LisH  MK   were also expressed 
at the same level as GFP-MK (  Fig. 5 B  ). Both GFP-MKLisHAA/
T723A and GFP-MKLisHAA/T723D were predominantly uni-
formly distributed between the cytoplasm and nucleus (  Fig. 5, 
E – G ).  However,   > 10%  of  GFP-MKLisHAA/T723D – expressing 
cells had elevated nuclear muskelin unlike either GFP-MKLisHAA 
or GFP-MKLisHAA/T723A cells. 18% of GFP-MKLisHAA/
T723A  –  expressing cells had elevated cytoplasmic muskelin 
(  Fig. 5 G  ). Thus, whereas functional impairment of LisH  MK  
strongly impacts the localization of GFP-MK    C35, the LisH 
mutation counteracts but does not completely abolish the distinct 
localizations of the TPPK mutants. 
  To identify a molecular basis for these activities, we per-
formed a yeast two-hybrid screen of a human skeletal muscle 
cDNA library for muskelin binding proteins. Of several initial 
candidates, only one was confi  rmed for specifi  c interaction with 
the muskelin bait under stringent conditions. This clone encoded 
aa 142  –  748 of RanBP9 (  NP_005484  ). Muskelin has also been 
identifi  ed as a yeast two-hybrid binding partner of RanBP9 
(  Umeda et al., 2003  ). RanBP9 is a multidomain intracellular 
protein (  Fig. 6 A  ) implicated as a scaffold of certain tyrosine kinase 
and adhesion receptors and nuclear signaling proteins (  Wang 
et al., 2002  ;   Rao et al., 2002  ;   Denti et al., 2004  ;   Cheng et al., 
2005  ;   Brunkhorst et al., 2005  ;   Hafi  zi et al., 2005  ). Endogenous 
RanBP9 was principally located in cytoplasm and on membranes, 
with lower levels in the nuclear fractions (  Fig. 6 B  ;   Denti et al., 
2004 ).  We  confi  rmed the specifi  c physical association of endog-
enous RanBP9 with muskelin in mammalian cells by coimmuno-
precipitation (  Fig. 6 C  ). RanBP9 binding was mediated by the 
LHKC domains and not by the DD (  Fig. 6 C  ). Further mapping 
within the LHKC domains demonstrated that the minimal frag-
ment to mediate strong association of endogenous RanBP9 was 
GFP-MKHKC (  Fig. 6 D  ). A lower level of binding occurred 
with the GPF-MKLHK protein that was equivalently immuno-
precipitated (  Fig. 6 D  ). Minor interaction was detected with the 
KC domains. There was no coimmunoprecipitation with HK, the 
kelch repeats, or C35 region alone. The status of C35 was impor-
tant for association of RanBP9 with KC because no RanBP9 was 
detected in immunoprecipitates of an equivalently expressed 
mutant, GFP-MKKCT723D (  Fig. 6 D  ). 
  We investigated the role of muskelin C35 region in more 
detail, in the context of full-length muskelin. The association 
of RanBP9 with GFP-MKT723A was indistinguishable from 
that of GFP-MK, whereas association with GFP-MKT723D 
was reduced (  Fig. 6 E  ). Deletion of the C35 region completely 
abolished binding (  Fig. 6 F  ). GFP-MKLisHAA and GFP-
MKLisHAA/T723A both associated strongly with RanBP9, 
whereas interaction with GFP-MKLisHAA/T723D was de-
creased (  Fig. 6 F  ). Notably, these results demonstrated different 
RanBP9 binding capacities of muskelin mutants with similar ma-
jority localization in the cytoplasm (GFP-MKLisHAA/T723A vs. 
GFP-MKLisHAA/T723D), and also similar binding capac-
ities by proteins with different distributions between cytoplasm 
and nucleus (GFP-MK vs. GFP-MKLisHAA). Thus, RanBP9 
possible functional motifs. C35 from vertebrate muskelin con-
tains a conserved consensus motif for phosphorylation by proline-
directed serine/threonine kinases, T  723 PPK 726   (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200801133/DC1;   Brown 
et al., 1999  ). This is supported by the presence of a conserved 
consensus cyclin binding motif within the DD (Fig. S1;   Brown 
et al., 1999  ). We addressed the putative functional signifi  cance 
of the TPPK motif through point mutations. GFP-MKT723A 
and GFP-MKT723D were expressed equivalently to GFP-MK 
(  Fig. 5 A  ). Whereas GFP-MKT723A had the same cytoplasmic 
localization as GFP-MK, GFP-MKT723D was mostly nuclear 
(  Fig. 5, C, D, and G  ). The redistribution of GFP-MKT723D was 
less than that of GFP-MK    C35 (45% of GFP-MKT725D cells 
  Figure 5.       Role of the C-terminal TPPK motif in coregulating muskelin 
localization.   (A and B) Immunoblots demonstrate equivalent expression 
of GFP-MK and the indicated point mutant proteins. Molecular mass 
markers are shown in kilodaltons. (C  –  F) Merged confocal images show-
ing localization of GFP-tagged muskelin point mutants (green) in COS-7 
cells costained with DAPI (blue). Bars, 10   μ  m. (G) Quantiﬁ  cation of sub-
cellular localizations. Each column represents the mean from two to three 
independent experiments. Error bars indicate SEM. At least 500 cells 
were scored for each construct. The localization of each protein is also 
shown schematically.     733 MUSKELIN  –  R  AN  BP9 COMPLEX AND CELL MORPHOLOGY   • Valiyaveettil et al. 
express a FLAG-RanBP9uCRA deletion protein (not depicted). 
The C-terminal fragments FLAG-RanBP9LHuCRA and FLAG-
RabBP9HuCRA were very weakly expressed, yet specifi  c co-
immunoprecipitation with GFP-MK was detectable (  Fig. 7 C  ). 
Overall, we conclude that multiple domains of RanBP9 are nec-
essary for full muskelin-binding activity. 
  Morphological activity of muskelin depends 
on an active cytoplasmic restraint and 
RanBP9 binding 
  To understand how these newly defi  ned attributes of muskelin 
and RanBP9 underpin the activity of muskelin in cell spread-
ing and cytoskeletal organization, we prepared cells depleted 
of muskelin by two methods of siRNA-mediated transcriptional 
silencing. Pilot cyclohexamide treatment experiments indicated 
a protein half-life of less than 16 h (unpublished data). Effec-
tive silencing in A549 lung epithelial cells, which have strong 
expression of muskelin (  Adams and Zhang, 1999  ) and RanBP9 
(Fig. S3 C, available at http://www.jcb.org/cgi/content/full/jcb
.200801133/DC1), was achieved by stable expression of short 
hairpin RNAs (shRNAs) targeting human muskelin. 62 clones 
binding activity does not simply refl  ect cytoplasmic localiza-
tion of muskelin but correlates precisely with the activity status 
of C35. 
  Multiple domains of RanBP9 are needed for 
efﬁ  cient association with muskelin 
  We next developed a set of FLAG-tagged domain deletions of 
RanBP9[142  –  748] (  Fig. 7 A  ) to map regions important for the 
association with muskelin. The SPRY (Sp1a and ryanodine re-
ceptor) domain of RanBP9 interacts with the cytoplasmic do-
mains of several transmembrane receptors (  Wang et al., 2002  ; 
  Cheng et al., 2005  ;   Hafi  zi et al., 2005  ); however, FLAG-RanB-
P9SL (containing the SPRY and LisH domains;   Fig. 7 A  ) was 
not suffi  cient for interaction with muskelin (  Fig. 7 B  ). Indeed, 
FLAG-RanBP9[142  –  748] was the only protein within the set 
to associate strongly with GFP-MK (  Fig. 7 C  ). Interpretation 
of results with other domains was complicated by the low ex-
pression level of many of the domain deletions (  Fig. 7 C   and 
Fig. S2 [longer exposure], available at http://www.jcb.org/cgi/
content/full/jcb.200801133/DC1), likely indicative of defi  -
ciencies in protein folding and/or stability. It was not possible to 
  Figure 6.       Role of the C35 region in regulating 
RanBP9 binding by muskelin.   (A) Schematic 
diagram of RanBP9 domain architecture and 
the domains included in the yeast two-hybrid 
clone. (B) Localization of RanBP9 in subcellu-
lar fractions of C2C12 cells. Cy, cytosol; M, 
membranes; NE, nuclear extract; NP, nuclear 
pellet. (C) The domains sufﬁ  cient for coimmuno-
precipitation of endogenous RanBP9 with 
GFP-MK are included in the LHKC fragment. 
(D) Analysis of the minimal domain require-
ments within the LHKC domains for coimmuno-
precipitation of endogenous RanBP9. (E and F) 
Coimmunoprecipitation of endogenous RanBP9 
by GFP-MK is regulated by the status of mus-
kelin C35 region. (F) RanBP9 signal intensities 
normalized relative to GFP-MK immunoprecipita-
tion are given below the blot. All molecular mass 
markers are shown in kilodaltons. Results shown 
are representative of three experiments.     JCB • VOLUME 182 • NUMBER 4 • 2008  734
cifi  c increases in cell perimeter length and protrusions in FN-
adherent cells (  Fig. 8, C and D  ). 
 To identify the molecular basis for these phenotypic effects, 
we tested the functional consequences of restoring muskelin-
depleted A549 clone 3 cells with cDNAs encoding mutant (mouse) 
muskelins. GFP-MK/LisHAA and GFP-MKT723A had similar 
highly signifi  cant activities to GFP-MK in restoring normal cell 
morphology, whereas GFP-MKT723D and GFP-MK   C35  were 
inactive (  Fig. 8 E  ). Similarly, GFP-MKLisHAA/T723A was 
active, whereas GFP-MKLisHAA/T723D had reduced activity 
(  Fig. 8 E  ). We also compared the activities of the N- and C-terminal 
regions. GFP-LHKC was active, whereas GFP-DDL was not. 
Identical results were obtained with A549 MK-depleted clone 2 
cells (unpublished data). Thus, morphological activity depended 
on the status of C35 and not on LisH  MK . 
  In view that the association of muskelin with RanBP9 also 
depends on C35 region, we examined whether depletion of 
RanBP9 resulted in similar phenotypic alterations. Because it 
did not prove possible to generate viable long-term RanBP9 
knockdown cells (unpublished data), inducible transient knock-
down of RanBP9 was used. In comparison to A549 control cells, 
or cells induced for an irrelevant shRNA, RanBP9-depleted 
A549 cells adherent on FN had enlarged cell perimeters, caused 
by protrusive morphologies, and altered F-actin distributions 
particularly at cell edges (  Fig. 8 F  ). This phenotype matched 
that of muskelin-depleted A549 cells. We conclude that the mor-
phological activity of muskelin depends on the cytoplasmic pool 
of muskelin and a physiological level of RanBP9 binding. 
  Discussion 
  These novel data advance concepts of the mechanisms by which 
regulation of cell morphology is integrated with nucleocyto-
plasmic signaling. The majority of muskelin appears cytoplasmic 
by immunofl  uorescence in multiple mammalian cells ( Adams et al., 
1998  ;   Hasegawa et al., 2000  ;   Prag et al., 2004  ;   Ledee et al., 2005  ; 
  Kobayashi et al., 2007  ), yet rigorous subcellular fractionation of 
endogenous muskelin revealed a nuclear pool. Analysis of the lo-
calizations of muskelin domain deletions defi  ned that the distri-
bution of the full-length protein depends on an intricate molecular 
balance, in which the extreme C terminus provides a cytoplasmic 
restraint and the LisH motif contains a nuclear localization activ-
ity that is largely cryptic under standard conditions. We identify 
that muskelin interacts with RanBP9 via its HKC domains and 
that the status of C35 is important in regulating this interaction. 
We establish that depletion of either muskelin or RanBP9 has an 
impact on cell morphology and that the morphological activity of 
muskelin depends on its C-terminal region, which mediates cyto-
plasmic localization and RanBP9 binding. 
  In other proteins with LisH motifs, which include both 
cytoplasmic- and nuclear-located proteins, the LisH motifs are 
typically uncharged (  Emes and Ponting, 2001  ). Several have 
homodimerization activity that is important for protein function 
(  Kim et al., 2004  ;   Mikolajka et al., 2006  ). Interactions with cyto-
plasmic dynein or microtubules have been reported and the 
LisH motif of p220 
NPAT   is required for activation of histone tran-
scription (  Cahana et al., 2001  ;   Wei et al., 2003  ). A small number 
were established with two different shRNAs, and 3 clones with 
the largest reductions in muskelin protein (50  –  65% reduction) 
representing both shRNAs (Fig. S3 A) were used for detailed 
analyses. Muskelin expression was silenced in C2C12 mouse 
skeletal myoblasts by an independent methodology: transfec-
tion with a chemical siRNA duplex targeting a distinct point 
on the mouse transcript from the shRNAs to human muskelin. 
In C2C12 cells, muskelin protein was depleted by 50  –  60% after 
96 h compared with cells treated with control siRNA duplex 
(Fig. S3 B). 
  In agreement with previously reported effects of muskelin 
on adhesion, A549 muskelin-depleted clones were reduced in 
attachment to the TSP-1 C terminus (  Fig. 8 A  , shown for clones 
2 and 3). The cells had altered spreading behavior on fi  bronectin 
(FN), with signifi  cantly enlarged cell perimeters caused by in-
creased ruffl  ing and protrusive edges (  Fig. 8 B  ). These changes 
were muskelin-dependent because normal cell morphology was 
specifi  cally restored by expression of GFP-MK (i.e., mouse 
MK which is not targeted by the shRNA) in multiple muskelin-
depleted A549 clones (  Fig. 8 B  ). The phenotype was confi  rmed 
in muskelin siRNA-treated C2C12 cells, which had similar spe-
  Figure 7.       Multiple RanBP9 domains are needed for association with 
muskelin.   (A) Schematic diagram of the FLAG-tagged RanBP9 domains 
prepared for these experiments. SPRY, Sp1a and ryanodine receptor do-
main; L, LisH motif; H, CTLH motif; u, unique region; CRA, CT11/RanBP9 
domain. (B) Speciﬁ   c coimmunoprecipitation of FLAG-RanBP9[142  –  748] 
with GFP-MK. (C) Analysis of RanBP9 domain requirements for coimmuno-
precipitation with GFP-MK. The boxed inset is a longer exposure of three 
lysate lanes demonstrating the poorly expressed LHuCRA and HuCRA pro-
teins. Asterisks indicate observed weak speciﬁ  c coimmunoprecipitations. 
All molecular mass markers are shown in kilodaltons. Results shown are 
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cell culture conditions only a small fraction of endogenous muske-
lin is nuclear located. In the vinculin chimera, the C-terminal  –
 located  LisH MK   is very likely constitutively active. The experiments 
with muskelin mutants revealed that strong nuclear localization 
of muskelin depends on either deletion of the C terminus or in-
clusion of a phosphomimetic mutant within the C terminus. 
Thus, the major cytoplasmic localization of wild-type muskelin 
likely refl  ects the dominance of C35-dependent phosphoregu-
lated binding interactions with cytoplasmic proteins over the 
intrinsic nuclear localization activity of LisH  MK  , with the net re-
sult that LisH  MK   activity appears cryptic. These counterbalanc-
ing activities remain functional in the LHKC deletion mutant. 
In addition, we previously identifi  ed that the amino-terminal DD 
of proteins in mammalian genomes, including both muskelin and 
RanBP9, contain contiguous LisH and CTLH motifs. The func-
tional signifi  cance of the combined motif is unclear. The pres-
ence of highly conserved charged residues within the muskelin 
LisH-like motif is a unique feature that we demonstrate for the 
fi  rst time here to have functional activity in regulating the nuclear 
localization of muskelin or a heterologous protein, vinculin. 
BLASTP searches of GenBank with the muskelin LisH-like 
motif identify only the LisH motifs from other muskelins. 
We suggest it is appropriate to redesignate the muskelin LisH-
like motif as a nuclear localization motif. 
  Despite the potent activity of LisH  MK   in mediating nuclear 
localization of a heterologous protein, vinculin, under standard 
  Figure 8.       The morphological activity of muskelin de-
pends on cytoplasmic localization and RanBP9 binding.   
(A  –  D) siRNA-based depletion of muskelin leads to mor-
phological alterations. (A) Reduced attachment of A549 
cells with stable expression of muskelin-shRNA clone 2 
(cl2) and clone 3 (cl3) cells to the TSP-1 C-terminal protein 
T3  5-7  GCT. Adhesion assays were performed for 1 h under 
serum-free conditions as previously described (  Kvansakul 
et al., 2004  ). (B and C) Cell perimeter measurements 
for control and muskelin-depleted A549 (B) or C2C12 
(C) cells adherent on 50 nM FN for 1 h. (B) A549 lines 
were also compared after 48 h expression of GFP or 
GFP-MK. Only GFP-MK restored normal morphology. 
In each graph, each column represents the mean of three 
independent experiments. Error bars indicate SEM. *, P   ≤   
0.0001. (D) Representative F-actin organization in control 
and muskelin-depleted C2C12 cells under the same ex-
perimental conditions as in C. Bar, 10   μ  m. (E) Activity of 
muskelin mutants in restoring the morphology of muskelin-
depleted A549 clone 3 cells. GFP, GFP-MK, or the indi-
cated mutants were expressed in clone 3 cells for 48 h, 
the cells adhered to 50 nM FN for 1 h, and cell perimeter 
lengths of GFP-positive cells were measured. Each column 
represents the mean of three independent experiments. 
Error bars indicate SEM. *, P   ≤   0.00001. At least 500 
cells were scored per condition. (F) RanBP9 knockdown 
results in similar morphological changes in FN-adherent 
A549 cells. Where indicated, cells were treated with 
0.75   μ  g/ml doxycycline for 36 h. Each column represents 
the mean from   >  50 cells. Error bars indicate SEM. *, P   <   
0.0001. Insets show representative merged cell images of 
F-actin (green), DAPI (blue), and, where induced, shRNA 
transcript expression (red; RFP). Bar, 10   μ  m.     JCB • VOLUME 182 • NUMBER 4 • 2008  736
domains. We propose that the status of C35 controls RanBP9 
binding by the muskelin      propeller and that this is a central 
mechanism for regulating muskelin localization and, thereby, 
its morphological activity in cells. We have demonstrated that 
knockdown of either muskelin or RanBP9 leads to equivalent 
morphological alterations in which adherent cells adopt protru-
sive phenotypes. Receptor-bound RanBP9 might concentrate 
muskelin in proximity to submembranous sites of Erk signal 
activation and active morphological remodelling. For example, 
elevated RanBP9 levels alter cell migration behavior (  Wang 
et al., 2002  ;   Zou et al., 2003  ). 
  Our data also establish that nuclear-located forms of mus-
kelin are impaired for morphological activity. Thus, physio-
logical mechanisms to activate nuclear localization of muskelin 
can be seen as mechanisms that provide modulation of ECM-
dependent cell adhesion and spreading. It is well established 
that conversion between a protrusive or contractile phenotype 
has a major impact on cell behavior (  Cukierman et al., 2002  ). 
It will be of future interest to establish the functions of nuclear 
muskelin. The presence of muskelin in the salt-extractable nu-
clear fraction, but not the nuclear matrix, is suggestive of a 
regulatory rather than a structural role. One possibility is that 
nuclear muskelin functions via the RanBP9 complex. RanBP9 
is also present in the salt-extractable nuclear fraction and is 
  implicated in transcriptional regulation (  Rao et al., 2002  ;   Wang 
et al., 2002  ;   Denti et al., 2004  ). In initial support, our coimmuno-
precipitation data demonstrate that partially nuclear-located 
muskelin mutants associate effi  ciently with RanBP9. In con-
clusion, our data establish the muskelin  –  RanBP9 complex as 
a novel player in pathways of nucleocytoplasmic signaling and 
open new directions for understanding how nucleocyto  plasmic 
communication and morphological processes are integrated 
by cells. 
  Materials and methods 
  Cell lines and materials 
  Green monkey kidney COS-7 cells and A549 human lung epithelial cells 
were grown in DME containing 10% FCS. C2C12 mouse skeletal myo-
blasts were grown in DME containing 20% FCS. Leptomycin B and phos-
phatase inhibitor cocktails 1 and 2 were obtained from Sigma-Aldrich. 
Rabbit polyclonal antibodies to muskelin were as previously described 
(  Adams et al., 1998  ). In addition, a rabbit polyclonal antibody was raised 
against a MAP peptide corresponding to residues 37  –  51 of mouse muske-
lin according to standard procedures. Puriﬁ  ed immunoglobulin was pro-
duced by passing the sera over protein G  –  Sepharose CL (GE Healthcare), 
with extensive washing and elution in 0.2 M glycine, pH 2.8. Mouse 
monoclonal antibodies to     -actin (clone AC-15), ﬁ  brillarin (clone 38F3), 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were obtained 
from Abcam; to Ran (Clone 20) from BD Biosciences; to FLAG epitope 
(clone M2) and vinculin (clone VIN11.5) from Sigma-Aldrich; to GFP 
(clones 7.1 and 13.1 mixture) from Roche; and to HA tag (clone 262k) and 
cyclin B1 from Cell Signaling Technology. Goat anti  –  lamin B1 antibody was 
obtained from Santa Cruz Biotechnology, Inc. Goat anti-RanBP9 was ob-
tained from Abcam. Mouse monoclonal to RanBP9 (  Denti et al., 2004  ) was 
a gift from E. Bianchi (Institut Pasteur, Paris, France). Rhodamine-phalloidin 
was obtained from Sigma-Aldrich. TSP-1 C-terminal protein was prepared as 
previously described (  Kvansakul et al., 2004  ). Human plasma FN was ob-
tained from EMD. 
  Expression constructs 
  Mammalian expression plasmids encoding enhanced GFP-tagged mouse 
muskelin (GFP-MK); GFP-tagged DD (aa 1  –  159; GFP-MKDD), and GFP-tagged 
and the C-terminal half, comprising the kelch-repeats and C35, 
bind in trans (  Prag et al., 2004  ). Analogous to signal-activated 
cytoskeletal regulatory proteins (  Pufall and Graves, 2002  ), molec-
ular self-association might facilitate the autoinhibition of LisH  MK  
by C35. 
  Muskelin exists in cells as multiple isoelectric variants, 
some of which result from phosphorylation by protein kinase C 
(  Prag et al., 2007  ). Our data on the key role of the C35 region 
and the status of T723 for the subcellular localization of muske-
lin implicate phosphorylation by a proline-directed kinase as a 
physiological mechanism to relieve autoinhibition of LisH  MK  
activity. Muskelin was reported to physically associate with the 
p39 activator of cdk5 (  Ledee et al., 2005  ); however, we did not 
detect association of muskelin with p39, cdk5, or cyclins for 
cdk1 or cdk2 by coimmunoprecipitation (unpublished data). 
  Instead, the presence of both phosphorylation and cyclin bind-
ing motifs in muskelin (Fig. S1) implicates a transient substrate 
interaction with active cdks. Further research will be needed 
to defi  nitively identify the proline-directed kinases that medi-
ate  muskelin phosphorylation at residue T723. We speculate 
that dynamic phosphorylation and dephosphorylation might be 
linked to specifi  c cell cycle stages and/or in response to specifi  c 
environmental cues. 
  Another major conceptual outcome of this research is the 
identifi  cation of a novel functional role for the muskelin  –
  RanBP9 complex. RanBP9 is an evolutionarily conserved nucleo-
cytoplasmic protein implicated as a scaffold for receptors that 
network with the Erk1/2 pathway (  Wang et al., 2002  ;   Umeda 
et al., 2003  ;   Cheng et al., 2005  ). An emerging consensus places 
RanBP9 as a multifunctional protein that interacts with the cyto-
plasmic domains of cell surface receptors including c-Met, inte-
grin      subunit, and L1 adhesion protein. Interactions with nuclear 
proteins are also indicated (  Rao et al., 2002  ;   Wang et al., 2002  ; 
  Denti et al., 2004  ;   Brunkhorst et al., 2005  ;   Cheng et al., 2005  ; 
  Togashi et al., 2006  ;   Kobayashi et al., 2007  ). Biochemically, 
RanBP9 is a component of a large protein complex of unknown 
function (  Umeda et al., 2003  ;   Kobayashi et al., 2007  ). In this 
complex, RanBP9 or its  S .  cerevisiae  homologue, VID30p, asso-
ciates with several proteins that are conserved from plants to 
animals. Current data suggest that the complex could be both 
cytoplasmic and nuclear (  Pitre et al., 2006  ;   Kobayashi et al., 
2007  ). Muskelin is not encoded in plants or the   S. cerevisiae  
genome (  Prag et al., 2004  ), yet associates with the mammalian 
RanBP9 complex (  Kobayashi et al., 2007  ). We propose that mus-
kelin confers distinct functional capacities on the conserved com-
plex in which RanBP9 participates. 
  Our data establish that the status of muskelin C terminus 
and, thereby, RanBP9 binding are essential for the morphologi-
cal activity of muskelin. In general, the      propeller structure 
formed by repeated kelch motifs presents a large domain with 
multiple faces for binding interactions. There are precedents 
for intramolecular interactions with C-terminal sequences, and 
N-terminal sequences may also contribute to correct folding of 
the kelch-repeat      propeller (  Prag and Adams, 2003  ;   Li et al., 
2004  ;   Padmanabhan et al., 2006  ). For muskelin, C35 is not suf-
fi  cient to bind RanBP9, yet its status profoundly regulates the 
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2,000 rpm for 10 min at 4  °  C to separate nuclei from cytosol. Nuclei 
were washed twice in 100   μ  l of buffer 1 and incubated in 100   μ  l of 25% 
glycerol, 20 mM Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, pH 8.0, 
1 mM EGTA, 1 mM DTT, and 25 mM     -glycerophosphate containing pro-
tease and phosphatase inhibitor cocktails. Samples were rocked at 4  °  C 
for 20 min and centrifuged at 14,000   g   for 20 min. This fraction was 
collected as nuclear extract. The remaining nuclear matrix pellet was 
washed twice in buffer 1 and solubilized in SDS-PAGE sample buffer. 
Meanwhile, the cytosolic fraction was centrifuged at 100,000   g   for 1 h 
at 4  °  C to pellet the membrane fraction, which was solubilized in SDS-
PAGE sample buffer. All fractions were brought to equal volumes and 
protein content was determined for the cytosol and nuclear extract frac-
tions. Equalized aliquots (20   μ  g) were analyzed on 10% SDS-PAGE gels 
under reducing conditions and transferred to PVDF membranes. Blots 
were probed with antibodies to GAPDH, Ran, and lamin B1 for quality 
control of the fractionation, with anti-actin for normalization of loading, 
and with antibodies to muskelin or RanBP9, followed by appropriate sec-
ondary antibodies and development by enhanced chemiluminescence. 
  siRNA-mediated depletion of muskelin or RanBP9 
  Transient expression of siRNA duplexes was used to deplete muskelin in 
mouse C2C12 cells. To identify an active siRNA, COS-7 cells were tran-
siently transfected with GFP or GFP-muskelin and, 24 h later, retransfected 
using 4   μ  l of 50   μ  M SMARTpool siRNA (Thermo Fisher Scientiﬁ  c) and 4   μ  l 
Oligofectamine (Invitrogen). Cells were lysed in SDS-PAGE sample buffer 
after 48 or 72 h and analyzed for GFP by immunoblotting, with normaliza-
tion against     -actin. The SMARTpool siRNA produced an     45% decrease 
in muskelin protein at 72 h. Individual siRNA duplexes from the pool were 
tested for silencing by the same method, and the most active duplex (sense 
strand sequence 5    CAAAGGCGAUGGAGAAGAUUU), producing     70% 
depletion of GFP-MK, was chosen for depletion of endogenous mouse mus-
kelin. C2C12 mouse skeletal myoblasts were plated at 25,000 cells per 
37-mm well and transfected twice at 24-h intervals with 2   μ  l of 50   μ  M of 
the muskelin siRNA duplex or FITC-labeled scrambled control siRNA du-
plex and 10   μ  l of Lipofectamine 2000 reagent (Invitrogen) in 500   μ  l DME, 
according to manufacturer  ’  s instructions. Cells were lysed in SDS-PAGE 
sample buffer 48, 72, or 96 h later and analyzed for muskelin by immuno-
blotting. All blots were normalised against     -actin. 
  For stable depletion of human muskelin, A549 human lung carci-
noma cells were stably transfected with human muskelin shRNAs, sh2038 
(vector 1), or sh2024 (vector 2) in pSHAG-MAGIC2 vector or control 
shRNA vector (Thermo Fisher Scientiﬁ  c;   Paddison et al., 2004  ), using 
Polyfect transfection reagent (QIAGEN) for 40 h, followed by selection 
with 7.5   μ  g/ml puromycin. Puromycin-resistant clones were analyzed 
for muskelin protein level by immunoblotting, with normalization against   
  -actin. Quantitation was performed using Image J version 1.38 (National 
Institutes of Health). For transient depletion of RanBP9, A549 cells were 
transfected with pTRIPZ plasmid encoding for RanBP9 (#68195) or non-
targeting shRNA (#4743; Thermo Fisher Scientiﬁ  c), followed by selection 
and regrowth in 1.5   μ  g/ml puromycin for 10 d and then TET-ON induc-
tion of shRNA for 24  –  48 h with 0.75   μ  g/ml doxycycline. In this plasmid, 
RFP is induced as part of the same transcript as the shRNA. Induced and 
control cells were adhered to 50 nM FN for 1h, ﬁ  xed, stained with FITC-
phalloidin, and examined by laser confocal microscopy and morpho-
metric scoring. 
  Yeast two-hybrid screen 
  A yeast two-hybrid library screen was performed with a human adult 
skeletal muscle cDNA library in the pACT2 vector, pretransformed into   
S. cerevisiae   strain Y187 (Clontech Laboratories, Inc.). The library was 
screened for muskelin-interacting clones by mating for 20 h at 30  °  C with 
  S. cerevisiae   strain AH108 pretransformed with muskelin bait plasmid 
(pAS2-1/MK). This bait had no independent transcriptional activation 
activity or effect on mating efﬁ  ciency. The library contained 3   ×   10 
6   
independent clones. The mating mixture was plated on synthetic dropout 
    His/    Leu/    Trp minimal media, according to the library manufactur-
er  ’  s protocol, for 8 d at 30  °  C. The mating efﬁ  ciency was 13.1% and a 
total of 2.85   ×   10 
6   library clones were screened. 54 colonies were re-
covered and replated under more stringent selection (SD minimal media 
    Ade/    His/    Leu/    Trp containing 40   μ  g/ml X-    -Gal (Clontech Labo-
ratories, Inc.) to check for expression of the   MEL1   reporter and eliminate 
false positives. 41 blue colonies were obtained and restreaked on SD 
    Leu/    Trp/+X-    -Gal and SD   –  Ade/    His/    Leu/    Trp +X-    -Gal plates 
to check for maintenance of phenotype. Plasmid DNA was then isolated 
from single yeast colonies by the alkaline lysis method, transformed into 
kelch repeats and C terminus (aa 243-735; GFP-MKKC) were as previously 
described (  Prag et al., 2004  ). Additional deletion mutants (  Fig. 1 B  ) were 
prepared in GFP-tagged form by PCR of the selected region from mouse 
muskelin cDNA with the forward oligonucleotide primer containing an 
EcoR1 site and the reverse primer containing a KpnI site, according to stan-
dard molecular biology procedures (  Sambrook and Russel, 2001  ). 
The oligonucleotide primers used are listed in Table S1 (available at http://
www.jcb.org/cgi/content/full/jcb.200801133/DC1) and were synthe-
sized by Sigma-Aldrich. Digested PCR products were ligated into the EcoRI 
and KpnI sites of pEGFP-C2 (Clontech Laboratories, Inc.) with QuickLigase 
(New England Biolabs, Inc.). HA-tagged MK-DDL was subcloned into 
pcDNA3.1.   Gallus gallus   vinculin cDNA (gift of Robert Kypta, Imperial Col-
lege, London, England, UK) was subcloned into pcDNA3.1 V5 His (Invitro-
gen) by TOPO cloning, with introduction of a HpaI site at the 3     end of the 
ORF. The LisH-encoding region of mouse muskelin (aa 172  –  204) was ampli-
ﬁ  ed from cDNA with PCR primers introducing a Hpa I site at the 5     end and 
a XbaI site at the 3     end, respectively, digested with HpaI and XbaI and li-
gated in frame at the 3     end of the vinculin cDNA. cDNAs encoding do-
mains of human RanBP9 were subcloned into p3xFLAG (Sigma-Aldrich), 
using the primer pairs listed in Table S1. Point mutations were prepared with 
QuikChange II site-directed mutagenesis kit (Stratagene) and GFP-MK or 
GFP-MK    C35 as templates. All constructs were veriﬁ  ed by DNA sequencing 
across the 5     and 3     junctions with vector-speciﬁ  c primers and by resequenc-
ing the complete cDNAs using internal primers. Automated DNA sequencing 
was performed by Cleveland Clinic Foundation Molecular Biotechnology 
and Genomics cores. 
  Bioinformatics analysis 
  Muskelin protein sequences were as previously identiﬁ  ed  (  Adams et al., 
1998  ;   Adams and Zhang, 1999  ;   Adams, 2002  ;   Prag et al., 2004  ) or were 
identiﬁ  ed by BLAST searches of GenBank and the database of expressed se-
quence tags with mouse MK as the query. Sequence Logo analysis was per-
formed at WebLogo (http://weblogo.berkeley.edu;   Shaner et al., 2003  ; 
  Crooks et al., 2004  ). LisH motifs were collected from SMART (  Schultz et al., 
1998  ). Phosphorylation motifs were analyzed through Prosite (European Bio-
informatics Institute) and Scansite (Massachussetts Institute of Technology). 
  Fluorescence microscopy 
  Transient transfection of COS-7 cells was performed as previously described 
(  Prag et al., 2004  ). Cell-ECM adhesion of C2C12 or A549 cells was per-
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chemically competent   Escherichia coli   XL1Blue (Stratagene), and DNA 
minipreps prepared from multiple single colonies by QIAprep spin mini-
prep method (QIAGEN). To identify   E. coli   clones that contained pACT2 
library clones, DNAs were digested with HaeIII and clones producing re-
striction digest patterns similar to that of the pACT2 vector were chosen 
for DNA sequencing. DNAs were also transformed into   S. cerevisiae   
strain Y187 and tested for independent transcriptional activity and inter-
action with the muskelin bait by mating and plating on SD   –  Ade/    His/
    Leu/    Trp +X-    -Gal. Clones passing these criteria were screened for 
speciﬁ  city of interaction with muskelin by testing against lamin or synde-
can-1 baits and pAS2-1 vector. Only one category of clone, encoding 
RanBP9 aa 142  –  748, was conﬁ  rmed for speciﬁ  c interaction with muske-
lin bait by all these criteria. 
  Online supplemental material 
  Fig. S1 shows that vertebrate muskelin proteins contain a candidate con-
served proline-directed kinase phosphorylation motif (A) and a cyclin-binding 
motif (B). Fig. S2 shows longer exposure of the FLAG blot samples shown 
in   Fig. 7 C   to demonstrate the weak expression of some RanBP9 domain 
deletions. Fig. S3 shows muskelin depletion by stable shRNA expression in 
A549 cells or transient expression of siRNAs in C2C12 cells. Table S1 
show the oligonucleotide primers used to prepare muskelin or RanBP9 do-
main or point mutant constructs. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200801133/DC1. 
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